Novartis’ CAR-T therapy Kymriah hits endpoint in follicular lymphoma trial

5th August 2020 Uncategorised 0

Company expect to file regulatory submissions in 2021

More: Novartis’ CAR-T therapy Kymriah hits endpoint in follicular lymphoma trial
Source: News